Skip to content

Treatment of Postoperative Delirium With Continuous Theta Burst Stimulation

Treatment of Postoperative Delirium With Continuous Theta Burst Stimulation: an Exploratory Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05239897
Enrollment
20
Registered
2022-02-15
Start date
2022-02-07
Completion date
2023-03-15
Last updated
2024-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Delirium

Brief summary

To determine whether continuous theta burst stimulation can cure postoperative delirium in senior patients.

Detailed description

Postoperative delirium(POD), a syndrome characterized by an acute change in attention, awareness and cognition, is one of the most common postoperative complications among elderly patients. Impaired neuronal network connectivity is likely one of the several neurobiological processes that contribute to POD pathogenesis. Recently, continuous theta burst stimulation (cTBS) was demonstrated to improve cognitive function in patients with mild cognitive impairment.Recent research suggests that cTBS has positive effect on improving the connectivity and reorganization of the brain network. Therefore, we plan to conduct an exploratory study in participants undergoing elective surgeries to determine whether cTBS can cure POD in this senior patient population.

Interventions

Patients assessed for postoperative delirium will be treated by consist of 600 pulses per session, delivered over the right dorsolateral prefrontal cortex at 80% of resting motor threshold (RMT). Every session cTBS consists of 50 Hz triplets of pulses delivered at 5 Hz for 40 seconds for a total of 600 pulses. Every set simulation includes 3 sessions.

Sponsors

RenJi Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
60 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Aged between 60 to 80 years; * Having delirium after elective surgery; * Being able to complete cognitive assessment and confusion assessment methods (CAM); * Willing to participate before surgery and being competent to provide informed consent.

Exclusion criteria

* Having brain tumor, stroke, or mental disorders (e.g., depression or dementia); * Having contraindications of cTBS (e.g., head trauma, history of epilepsy or metal implants in the head or heart); * Participating in other clinical studies.

Design outcomes

Primary

MeasureTime frameDescription
Cure rate of POD after a single cTBS treatment7 days after surgeryNo POD was evaluated by CAM at 1 hour after a single cTBS treatment on the day of the first occurrence of POD and at any time point thereafter.

Secondary

MeasureTime frameDescription
Cure rate of POD after multiple cTBS treatments7 days after surgeryNo POD was evaluated by CAM at 1 hour after two or three cTBS treatments and at any time point thereafter.
Severity of postoperative delirium changed after each cTBS treatment7 days after surgerySeverity of postoperative delirium on postoperative day 1 to 7 will be defined according to MDAS.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026